Postoperative statin use is associated with a 26% reduction in breast cancer-specific mortality, with more pronounced effects observed in patients with estrogen receptor-positive (ER+), postmenopausal, and advanced-stage disease. The gene discussed is ESR1; the disease is breast cancer.